Literature DB >> 33323164

Evaluation of Nutritional Gel Supplementation in C57BL/6J Mice Infected with Mouse-Adapted Influenza A/PR/8/34 Virus.

Jessica L Felgenhauer1, Jourdan E Brune1, Matthew E Long2, Anne M Manicone2, Mary Y Chang1, Thea L Brabb1, William A Altemeier2, Charles W Frevert3.   

Abstract

Mice are a common animal model for the study of influenza virus A (IAV). IAV infection causes weight loss due to anorexia and dehydration, which can result in early removal of mice from a study when they reach a humane endpoint. To reduce the number of mice prematurely removed from an experiment, we assessed nutritional gel (NG) supplementation as a support strategy for mice infected with mouse-adapted Influenza A/Puerto Rico/8/34 (A/PR/8/34; H1N1) virus. We hypothesized that, compared with the standard of care (SOC), supplementation with NG would reduce weight loss and increase survival in mice infected with IAV without impacting the initial immune response to infection. To assess the effects of NG, male and female C57BL/6J mice were infected with IAV at low, intermediate, or high doses. When compared with SOC, mice given NG showed a significant decrease in the maximal percent weight loss at all viral doses in males and at the intermediate dose for females. Mice supplemented with NG had no deaths for either sex at the intermediate dose and a significant increase in survival in males at the high viral dose. Supplementation with NG did not alter the viral titer or the pulmonary recruitment of immune cells as measured by cell counts and flow cytometry of cells recovered in bronchoalveolar lavage (BAL) fluid in either sex. However, mice given NG had a significant reduction in IL6 and TNFα in BAL fluid and no significant differences in CCL2, IL4, IL10, CXCL1, CXCL2, and VEGF. The results of this study show that as compared with infected SOC mice, infected mice supplemented with NG have reduced weight loss and increased survival, with males showing a greater benefit. These results suggest that NG should be considered as a support strategy and indicate that sex is an important biologic variable in mice infected with IAV.

Entities:  

Mesh:

Year:  2020        PMID: 33323164      PMCID: PMC7754200          DOI: 10.30802/AALAS-CM-20-990138

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   0.982


  55 in total

Review 1.  Taste receptor genes.

Authors:  Alexander A Bachmanov; Gary K Beauchamp
Journal:  Annu Rev Nutr       Date:  2007       Impact factor: 11.848

2.  Estimating influenza-associated deaths in the United States.

Authors:  William W Thompson; Matthew R Moore; Eric Weintraub; Po-Yung Cheng; Xiaoping Jin; Carolyn B Bridges; Joseph S Bresee; David K Shay
Journal:  Am J Public Health       Date:  2009-10       Impact factor: 9.308

3.  Sex influences immune responses to viruses, and efficacy of prophylaxis and treatments for viral diseases.

Authors:  Sabra L Klein
Journal:  Bioessays       Date:  2012-09-26       Impact factor: 4.345

4.  Markers for predicting death as an outcome for mice used in infectious disease research.

Authors:  Rita A Trammell; Linda A Toth
Journal:  Comp Med       Date:  2011-12       Impact factor: 0.982

5.  Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia.

Authors:  Travis B Nielsen; Jun Yan; Brian Luna; Brad Spellberg
Journal:  J Vis Exp       Date:  2018-06-28       Impact factor: 1.355

6.  Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection.

Authors:  John R Teijaro; Kevin B Walsh; Stuart Cahalan; Daniel M Fremgen; Edward Roberts; Fiona Scott; Esther Martinborough; Robert Peach; Michael B A Oldstone; Hugh Rosen
Journal:  Cell       Date:  2011-09-16       Impact factor: 41.582

7.  The lung environment controls alveolar macrophage metabolism and responsiveness in type 2 inflammation.

Authors:  Freya R Svedberg; Sheila L Brown; Maria Z Krauss; Laura Campbell; Catherine Sharpe; Maryam Clausen; Gareth J Howell; Howard Clark; Jens Madsen; Christopher M Evans; Tara E Sutherland; Alasdair C Ivens; David J Thornton; Richard K Grencis; Tracy Hussell; Danen M Cunoosamy; Peter C Cook; Andrew S MacDonald
Journal:  Nat Immunol       Date:  2019-04-01       Impact factor: 31.250

8.  Pulmonary immune cells and inflammatory cytokine dysregulation are associated with mortality of IL-1R1 -/-mice infected with influenza virus (H1N1).

Authors:  Lei Guo; Yan-Cui Wang; Jun-Jie Mei; Ruo-Tong Ning; Jing-Jing Wang; Jia-Qi Li; Xi Wang; Hui-Wen Zheng; Hai-Tao Fan; Long-Ding Liu
Journal:  Zool Res       Date:  2017-05-18

9.  Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017.

Authors: 
Journal:  Lancet Respir Med       Date:  2018-12-12       Impact factor: 30.700

10.  Administration of bleomycin via the oropharyngeal aspiration route leads to sustained lung fibrosis in mice and rats as quantified by UTE-MRI and histology.

Authors:  Christine Egger; Catherine Cannet; Christelle Gérard; Elizabeth Jarman; Gabor Jarai; Agnès Feige; Thomas Suply; Arthur Micard; Andrew Dunbar; Bruno Tigani; Nicolau Beckmann
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

View more
  2 in total

1.  Type I Interferon Signaling Increases Versican Expression and Synthesis in Lung Stromal Cells During Influenza Infection.

Authors:  Jourdan E Brune; Mary Y Chang; William A Altemeier; Charles W Frevert
Journal:  J Histochem Cytochem       Date:  2021-10-19       Impact factor: 2.479

2.  Persisting Microbiota and Neuronal Imbalance Following T. gondii Infection Reliant on the Infection Route.

Authors:  Timothy French; Johannes Steffen; Albert Glas; Lisa Osbelt; Till Strowig; Björn H Schott; Thomas Schüler; Ildiko Rita Dunay
Journal:  Front Immunol       Date:  2022-07-11       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.